Stella McCartney Launches Breast Cancer Charity, Taps Idris Elba for Campaign


Stella McCartney has launched Stella McCartney Cares, a charity registered in the U.K., that will support breast cancer awareness, among other causes. The designer has long been an advocate for breast cancer awareness; her mother Linda McCartney died from the disease in 1998. The platform's first initiative will be the donation of 1,000 of McCartney's Louis Listening post-operative mastectomy compression bras to women undergoing breast cancer treatment. The bra can be requested on

"It's a cause so close to my heart and the reason I designed the Louise Listening bra is my experience of seeing someone that I loved go through such a traumatizing operation, a mastectomy," said McCartney. "I found that the mastectomy bras available at the time were just another moment where [breast cancer patients] lost their femininity and they lost a sense of who they were as a woman. I wanted to create a product that really is still beautiful and still feminine and still celebrates the power of being a woman."

The Louise Listening bra was introduced in 2015 and the 2018 version has been modified to include soft internal pockets for use with prosthesis, wide adjustable straps and an extended size range of small to extra large. Stella McCartney Cares Pink will focus on building relationships with hospitals, charities and support centers devoted to breast cancer.

To accompany the launch of, McCartney released a breast cancer awareness campaign short film called "All Is Love" featuring Idris Elba. Sofia Vergara is the face of McCartney's annual limited-edition breast cancer awareness lingerie set.

'Wanderlust' Stars Toni Collette as a Therapist With an Elastic Definition of Marriage
ThredUp's UpCycle Helps Brands and Retailers Cash in on Recycling
Will Peltz Talks Gay Kiss at Stella McCartney

More Related News

Novartis' breast cancer treatment wins FDA approval

The U.S. Food and Drug Administration (FDA) said on Friday that it had approved Novartis AG's treatment in combination with a hormone therapy for postmenopausal women, as well as for men, with a form of advanced breast cancer. The drug, alpelisib, to be marketed under the brand name Piqray, belongs to a class of drugs known as PI3K inhibitors and is the first of its kind to be approved, the FDA said in a statement. "Piqray is the first PI3K inhibitor to demonstrate a clinically meaningful benefit in treating patients with this type of breast cancer," the FDA said.

Giuliana & Bill Rancic Want You to Help People Affected by Cancer
Giuliana & Bill Rancic Want You to Help People Affected by Cancer

Here's what you probably know about reality television stars Giuliana and Bill Rancic: They rose to fame as co-anchor of E! News and winner of The Apprentice, respectively, and for sharing their daily lives on the reality series Bill & Giuliana. And here's what you probably don't know about them: They want the public to […]

Pharma Stock Roundup: MRK
Pharma Stock Roundup: MRK's Cancer Biotech Buyout, ABBV, LLY's Pipeline Updates

Key highlights of the week include Merck's (MRK) offer to buy private cancer biotech and AbbVie (ABBV) and Lilly's (LLY) updates from clinical studies.

3 Stocks to Win Big in the Fight Against Cancer
3 Stocks to Win Big in the Fight Against Cancer

We highlight three stocks that are using innovative ways to treat cancer, also called malignancy. These stocks are also great long-term investments.

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply


Top News: Style

Hit "Like"
Don't miss any important news
Thanks, you don't need to show me this anymore.